Recent Finacing
Recent Raise
SpliSense is a clinical-stage biotechnology company developing inhaled antisense oligonucleotide (ASO) therapies for pulmonary diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Splisense.
